U.S. Entertainment Stock News

ANI Pharmaceuticals (ANIP) is drawing attention after its rare disease franchise delivered a major revenue surge over the past year. This growth has been powered by booming demand for Cortrophin Gel and expanded outreach to prescribers and patients. See our latest analysis for ANI Pharmaceuticals. Following the breakout performance in rare disease treatments, ANI Pharmaceuticals’ shares have caught investors’ attention. After a stellar 50% year-to-date share price return and a one-year total...

International Flavors & Fragrances (IFF) shares have shown modest gains this week, catching the attention of investors interested in stability and long-term value. The stock’s recent performance prompts a closer look at where things stand today. See our latest analysis for International Flavors & Fragrances. After a challenging start to the year, International Flavors & Fragrances shares have begun to regain some ground. Short-term momentum is picking up as the 7-day and 30-day share price...

NextEra Energy (NEE) has seen its stock make steady moves in recent weeks, drawing increased investor interest. With performance picking up over the past three months, some are now re-examining how the company’s value stacks up. See our latest analysis for NextEra Energy. Momentum has quietly been building for NextEra Energy, with a 14.8% gain in the past three months and a 12.9% total shareholder return over the last year. This suggests that confidence is returning and investors are looking...

CommScope (COMM) caught the market’s attention after its strong Q3 results. The standout CCS segment delivered solid cash flow just before its planned sale to Amphenol, and a potential special dividend is on the horizon. See our latest analysis for CommScope Holding Company. CommScope’s significant 22.6% one-month share price return and the massive 275.8% year-to-date gain tell a clear story: momentum is building quickly on the back of upbeat earnings, exciting new product launches such as...

If you have ever wondered whether Meta Platforms is a bargain or if the stock's price really reflects all it has to offer, you are in the right place. Meta's stock price has seen short-term ups and downs, climbing 6.4% in the past week but dropping 13.8% over the last month. Over three years, it has still produced a strong 484.8% return. Recently, shares have been especially volatile as media coverage highlighted Meta’s expansion into artificial intelligence and regulatory headlines...

Chubb (CB) shares inched up slightly in recent trading, with a 0.7% daily gain as investors weigh the company's performance over the past month. The insurer's stock has returned over 5% in that period. See our latest analysis for Chubb. Chubb’s recent momentum comes after a steady run, with a 30-day share price return of 5.6% helping to push its stock to $297.77. While that recent strength stands out, the one-year total shareholder return of 4.6% suggests long-term gains have moderated since...

Amgen recently announced that the FDA granted full approval to IMDELLTRA (tarlatamab-dlle) for adults with extensive stage small cell lung cancer (ES-SCLC) whose disease progressed after platinum-based chemotherapy, and the NCCN updated its guidelines to make IMDELLTRA the only Category 1 preferred option for this group. This approval follows significant clinical trial results, with IMDELLTRA reducing the risk of death by 40% and extending median overall survival for ES-SCLC patients...

EPAM Systems (EPAM) saw shares climb after its latest earnings report came in above expectations, with management also raising its outlook for the year. The company pointed to strong demand in AI, cloud, automation, and modernization services. See our latest analysis for EPAM Systems. EPAM’s upbeat quarterly results and raised outlook sparked a sharp rally, with the stock jumping 17% over the past month. Even with this momentum, EPAM’s year-to-date share price return remains negative. Its...

Johnson & Johnson recently announced that new Phase 3b APEX study data presented at the Inflammatory Skin Disease Summit 2025 showed TREMFYA® continued to reduce signs and symptoms of active psoriatic arthritis and inhibit progression of structural joint damage for 48 weeks. This positive clinical evidence supported Johnson & Johnson's supplemental Biologics License Application to the FDA, aimed at updating TREMFYA®'s label to reflect benefits in preventing structural damage in adult...

Recent remarks from New York Federal Reserve President John Williams about possible rate adjustments sent banking stocks higher. Cadence Bank (CADE) saw its shares climb, which points to investor optimism despite ongoing questions around loan quality across the sector. See our latest analysis for Cadence Bank. Cadence Bank’s share price is showing renewed momentum, gaining 8.6% over the past month and now up 17.6% year-to-date. That rally was sparked by excitement around possible interest...

Tyra Biosciences (TYRA) has begun dosing participants in a Phase 2 clinical trial of dabogratinib, targeting achondroplasia in children. This milestone highlights the company’s recent pipeline progress and has fueled market interest. See our latest analysis for Tyra Biosciences. Tyra’s recent 52-week high and accelerated 90-day share price return of 70% reflect a surge in optimism since announcing the Phase 2 study and affirming its growth story. Momentum has been building for months, with a...

Carter's (CRI) shares have edged higher this week, up about 4% in the past day and over 9% for the week. The movement comes as investors assess recent performance trends and consider the company's long-term prospects. See our latest analysis for Carter's. Despite a sharp rally this week, Carter's share price is still well below its earlier highs, with a year-to-date return of -42.02%. For context, the total shareholder return over the past year is -40.39%, which points to longer-term...

Victory Capital Holdings (VCTR) is back in the spotlight after Merion Road Capital Management re-initiated its stake, following the company’s acquisition of Amundi US. The deal increases assets under management and highlights new cross-selling possibilities for Victory Capital. See our latest analysis for Victory Capital Holdings. Victory Capital’s recent moves have sparked interest, but the stock’s share price has edged lower, with a year-to-date decline of 4.2%. While momentum has cooled in...

Charles Schwab (SCHW) shares have edged slightly higher today, with the price moving up following what appears to be a relatively quiet news cycle. Investors are taking stock of the company’s recent performance trends and long-term returns. See our latest analysis for Charles Schwab. After rallying strongly earlier in the year, Charles Schwab's share price has cooled, down 4.3% over the past month and 6.5% in the past quarter, even as its year-to-date gain remains a robust 22.9%. With a...

American Electric Power Company recently announced a follow-on equity offering of common stock, aiming to raise US$3.5 billion through an at-the-market transaction. This corporate action is significant as it can impact the company’s capital structure, funding flexibility, and investor perception moving forward. We will explore how this equity offering shapes the company’s growth investment narrative, given its influence on capital strategy and financial resources. Outshine the giants: these...

Earlier this month, Impinj unveiled new Gen2X innovations at its Gen2X Solutions Developers Conference 2025, introducing capabilities that inhibit counterfeit items, reduce stray tag reads, and improve tag detection in retail and industrial settings. By expanding Gen2X support to its M770 and M780 endpoint ICs and upgrading its reader and software portfolios, Impinj is addressing key challenges in product authenticity, inventory efficiency, and scalability for IoT partners across industries...

Helmerich & Payne (HP) has drawn fresh attention after Goldman Sachs upgraded its outlook. The company also announced plans to resume operations on several rigs in Saudi Arabia. These moves highlight a shifting landscape for the drilling firm. See our latest analysis for Helmerich & Payne. After a tough year marked by a decline of 16.1% in total shareholder return, Helmerich & Payne’s stock is showing signs of renewed investor interest. The share price has rebounded 39.5% over the past 90...

Semtech (SMTC) recently saw its stock move higher, with shares climbing over 2% in the last trading day. Investors have taken notice of the semiconductor company's performance, particularly given its solid gains over the past month. See our latest analysis for Semtech. Semtech’s momentum seems to be building, with a 1-day share price return of 2.5% and an impressive 14.5% return over the last week, capped by a robust 23.5% gain in the most recent quarter. Looking longer term, shareholders...

Earlier in November, Avis Budget Group was ranked third behind Enterprise and Hertz as the best domestic car rental company at the Travvy Awards, based on votes from thousands of travel advisors. Recent reports highlight disappointing rental demand, diminishing returns on capital, and constrained cash reserves, raising new questions about Avis Budget Group’s ability to maintain profitability without resorting to costly financing options. We will examine how rising concerns over Avis Budget...

US Foods Holding (USFD) shares have been trending higher over the past month, with the stock gaining around 6%. Investors appear interested in how the company’s fundamental performance is holding up, especially as market sentiment shifts. See our latest analysis for US Foods Holding. Building on its upward momentum, US Foods Holding has seen a 17.05% year-to-date share price return, fueled by solid execution and a pickup in investor confidence. With a 12.93% total shareholder return over the...

Earlier this month, Simon Property Group announced the acquisition of Phillips Place, a 134,000-square-foot open-air retail center in Charlotte’s SouthPark neighborhood, adding specialty retail, dining, a hotel, and multi-family residences to its portfolio. This purchase reinforces Simon’s continued efforts to strengthen mixed-use and experience-focused destinations, shaping its approach to long-term property enhancement and community engagement. We'll look at how Phillips Place's addition...

In November 2025, Labcorp announced a series of developments, including new clinical evidence for its Plasma Detect molecular residual disease test, a digital pathology and AI collaboration with Lunit for oncology research, and the upcoming appointment of Victor Bulto, a global pharmaceutical executive, to its Board of Directors effective December 1, 2025. The peer-reviewed studies underscoring Plasma Detect's value in tracking residual cancer and the Lunit collaboration point to Labcorp's...

StoneX Group Inc. recently reported fourth-quarter earnings for the period ended September 30, 2025, posting revenue of US$32.72 billion and net income of US$85.7 million, both up from the previous year. These results reflect continued operational strength, with earnings per share showing modest growth and signaling resilience in the company’s global financial services operations. We’ll explore how StoneX’s improved revenue and net income shape the company’s investment narrative and outlook...

Interface (TILE) just announced plans to redeem its entire $300 million in 5.50% Senior Notes due 2028, but the move hinges on successfully completing new financing or refinancing transactions. This signals a meaningful shift in how Interface is managing its debt. See our latest analysis for Interface. Interface’s share price has shown renewed momentum lately, climbing 3.3% in a day and nearly 10% this past week, likely buoyed by the news of potential note redemption and a proactive debt...